Senior insider sale
Chief Medical Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$6.23M
86.29K shares
What this filing means
SLOAN SHELDON plans to sell 86.29K shares of SPYRE THERAPEUTICS, INC. valued at approximately $6.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001950047-26-003923
Officer· Chief Medical Officer
Since Oct 2024
86.29K
Shares to sell
$6.23M
Approx. market value
78.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/1/2026
78.33KTotal acquired78.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Exercise of Stock Options Cash | 78.33K | — |
| Total | 78.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.96K
Market value
$397.9K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
78.33K
Market value
$5.83M
5/1/2026
Total
Units
86.29K
Value
$6.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 7.96K | $397.9K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 78.33K | $5.83M | NASDAQ | Planned |
| Total | 86.29K | $6.23M | ||